Spain pharmacy body issues counselling standards for liraglutide initiation
The evidence base is thin and the document says so, which is to its credit.
The archive — 2026
Page 3 of 34 of this archive, newest first.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Saudi Arabia health authority warns on falsified tirzepatide pens
Reported from the analysis, not from a warning notice.
Four millimetres is enough, and the data says so
Longer needles reach muscle in lean limbs, and intramuscular delivery of a long-acting depot changes absorption in ways nobody wants.
New Zealand caps semaglutide prescribing to 17 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Inspectors cite the online reseller trading as Adamant Research Supply over sterility assurance
The observation that closes a facility is rarely the dramatic one.
The 26-day notice: how a compounding wind-down works in the United Kingdom
The document is four pages. Three of them are about dates.
LEADER misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
One method is one opinion
Aggregates dissociate in the mobile phase and are recorded as monomer. Only a size-based separation reports them.
A reference interval is not a target, and a result outside one is not a diagnosis
Two sources of noise sit under every number: how reproducible the assay is, and how much the analyte varies within the same person on the same day.
The badge is about a sample. The listing is about a product.
A badge asserts that something was tested. It does not assert what, when, on whose sample, by what method, or whether the lot on sale is the lot that was tested.
Australia health authority warns on falsified liraglutide pens
Reported from the analysis, not from a warning notice.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
A shortage listing ends. 15 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
What changed at FGP in June, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Seven days, four weeks, one number: how liraglutide exposure actually accumulates
Half-life, accumulation ratio and time to steady state are three separate quantities, and confusing them produces most of the bad advice in circulation.
What a split-sample exercise can establish, and what it cannot
Duplicate submissions under different names test within-laboratory repeatability, which is a different quantity from between-laboratory reproducibility.
Calder Vale Peptides of Skipton closes after 22 years
A proper account of an operation that existed, and of what closing it cost.
Norway health authority warns on falsified liraglutide pens
Reported from the analysis, not from a warning notice.
Nantong export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
STEP 4 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The withdrawal trials, read as designs rather than warnings
Three randomised withdrawal designs have tested what happens when treatment stops. Their results are consistent and they are consistently misreported.
Background rates, and why they matter for attribution
Pancreatitis is rare, was adjudicated in the outcome programmes, and did not show the imbalance early case reports suggested.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
What changed at SWB in June, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What the new New Zealand guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What a laboratory knows about the material it receives
Chain of custody, in a regulated setting, begins at sampling. Here it begins when the package arrives.
Two per cent water sounds like nothing and is not nothing
Residual moisture is measured routinely in regulated manufacture, is reported almost nowhere in this trade, and predicts long-term stability better than any other single…
Saudi Arabia health authority warns on falsified tirzepatide pens
Reported from the analysis, not from a warning notice.
SURPASS-3 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.